Clinical Trial Update: Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the effect of ciclesonide HFA nasal aerosol on the hypothalamic-pituitary-adrenal axis in perennial allergic rhinitis; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• ciclesonide HFA nasal aerosol (ciclesonide)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2012-07-19